
Photo from Tom Powles/Twitter
Mar 17, 2024, 19:51
Tom Powles: New ESMO’s guidlines for advanced bladder cancer Annals of Oncology – Enforumab Vedotin and pembrolizumab is the new standard of care
Tom Powles, Director of Barts Cancer Center, shared a post on X:
“New ESMO’s guidelines for advanced bladder cancer Annals of Oncology. Enforumab Vedotin and pembrolizumab is the new standard of care. Platinum therapy is now 2nd line and eligibility less relevant.”
View the article.
Source: Tom Powles/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 20:53